Collectively, these findings suggest that activation of the plasminogen-plasmin pathway is one of the regulatory mechanisms underlying the beneficial effects of bromelain on the NAFLD-induced deregulation of the coagulation system. The gene discussed is PLG; the disease is metabolic dysfunction-associated steatotic liver disease.